Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL395003 | 0.86 | — | — | |
| Iodide SCHEMBL394767 | 0.86 | — | — | |
| Fluoride SCHEMBL28089628 | 0.80 | — | — | |
| Bromide SCHEMBL30918596 | 0.68 | — | — | |
| Bromide SCHEMBL302507 | 0.68 | ALDH1A1 (0.43) | — | |
| Bromide SCHEMBL125963 | 0.68 | — | — | |
| SCHEMBL4817897 | 0.62 | — | — | |
| Bromide SCHEMBL248705 | 0.60 | — | — | |
| Isopropylamine SCHEMBL1579520 | 0.57 | — | — | |
| Bromide SCHEMBL10968798 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 429 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025242747-A1 | MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS | MERCK PATENT GMBH (DE) | 2025-11-27 | — | — | WO | claimed |
| CN-115724739-A | Resorcinol carboxylate metal complex, eutectic crystal or salt, and preparation method and application thereof | 山东特珐曼药业有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-115626897-A | Preparation method of 5-amino-4, 6-diisopropyl pyrimidine | 常州佳德医药科技有限公司 | 2023-01-20 | — | — | CN | claimed |
| EP-3162786-B1 | METHOD FOR PRODUCING 4-ISOPROPYL-3-METHYLPHENOL | OSAKA KASEI CO LTD (JP) | 2019-08-28 | — | — | EP | claimed |
| US-10252964-B2 | Producing method for 4-isopropyl-3-methylphenol | OSAKA KASEI CO., LTD. (JP) | 2019-04-09 | — | — | US | claimed |
| US-20170129836-A1 | PRODUCING METHOD FOR 4-ISOPROPYL-3-METHYLPHENOL | OSAKA KASEI CO., LTD. (JP) | 2017-05-11 | — | — | US | claimed |
| EP-3162786-A1 | METHOD FOR PRODUCING 4-ISOPROPYL-3-METHYLPHENOL | Osaka Kasei Co., Ltd. (JP) | 2017-05-03 | — | — | EP | claimed |
| US-12582657-B2 | Combination therapy including a KRAS G12C inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers | AMGEN INC. (US) | 2026-03-24 | — | — | US | disclosed |
| EP-4048671-B1 | PYRIDOPYRIMIDINE DERIVATIVES USEFUL AS KRAS G12C AND KRAS G12D INHIBITORS IN THE TREATMENT OF CANCER | AMGEN INC (US) | 2026-03-18 | — | — | EP | disclosed |
| EP-4709480-A1 | 5,6-FUSED BICYCLIC AMIDES AND COMPOSITIONS FOR USE AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS | Amgen Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| US-20260062412-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITY | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-4126835-B1 | INHIBITORS OF ANTIGEN PRESENTATION BY HLA-DR | JANSSEN PHARMACEUTICA NV (BE) | 2026-02-18 | — | — | EP | disclosed |
| EP-4684786-A2 | PYRIDOPYRIMIDINE DERIVATIVES USEFUL AS KRAS G12C AND KRAS G12D INHIBITORS IN THE TREATMENT OF CANCER | Amgen Inc. (US) | 2026-01-28 | — | — | EP | disclosed |
| EP-2035436-A1 | FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS | UCB Pharma S.A. (BE) | 2009-03-18 | — | — | EP | disclosed |
| WO-2009029592-A1 | HETEROBICYCLIC-SUBSTITUTED QUINOLONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | KALYPSYS, INC. (US) | 2009-03-05 | — | — | WO | disclosed |
| WO-2008001076-A1 | FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS | UCB PHARMA S.A. (BE) | 2008-01-03 | — | — | WO | disclosed |
| US-20070203159-A1 | Purine compounds | UNIVERSITETET I OLSO (NO) | 2007-08-30 | — | — | US | disclosed |
| EP-0013082-B1 | PROCESS FOR PRODUCING STEROID COMPOUNDS HAVING AN OXOGROUP IN THE SIDE CHAIN | TEIJIN LIMITED (JP) | 1982-12-15 | — | — | EP | disclosed |
| US-4298537-A | Process for producing steroid compounds having an oxo group in the side chain | TEIJIN LIMITED (JP) | 1981-11-03 | — | — | US | disclosed |
| EP-0013082-A1 | Process for producing steroid compounds having an oxogroup in the side chain | TEIJIN LIMITED (JP) | 1980-07-09 | — | — | EP | disclosed |